Truist Financial Issues Positive Forecast for Integral Ad Science (NASDAQ:IAS) Stock Price

Integral Ad Science (NASDAQ:IAS) had its price target hoisted by Truist Financial from $16.00 to $17.00 in a research report released on Monday,Benzinga reports. Truist Financial currently has a buy rating on the stock.

Other equities research analysts have also issued research reports about the company. Piper Sandler lowered their price objective on Integral Ad Science from $18.00 to $16.00 and set an “overweight” rating on the stock in a report on Wednesday, November 13th. Benchmark reaffirmed a “hold” rating on shares of Integral Ad Science in a report on Friday. Oppenheimer reaffirmed an “outperform” rating on shares of Integral Ad Science in a research note on Friday. Craig Hallum cut their price target on Integral Ad Science from $18.00 to $16.00 and set a “buy” rating for the company in a report on Wednesday, November 13th. Finally, Scotiabank began coverage on shares of Integral Ad Science in a report on Friday. They set a “sector perform” rating and a $12.00 price objective on the stock. Four equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, Integral Ad Science currently has a consensus rating of “Moderate Buy” and a consensus price target of $15.06.

Integral Ad Science Stock Up 1.9 %

Integral Ad Science stock opened at $10.72 on Monday. The company has a market capitalization of $1.74 billion, a P/E ratio of 53.60, a PEG ratio of 1.06 and a beta of 1.46. Integral Ad Science has a fifty-two week low of $7.98 and a fifty-two week high of $13.62. The stock has a 50-day simple moving average of $10.34 and a 200-day simple moving average of $10.82. The company has a debt-to-equity ratio of 0.07, a quick ratio of 3.71 and a current ratio of 3.71.

Integral Ad Science (NASDAQ:IAS) last announced its earnings results on Friday, February 28th. The company reported $0.09 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.03). Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The business had revenue of $153.00 million during the quarter, compared to analysts’ expectations of $148.83 million. During the same period in the previous year, the company posted $0.06 earnings per share. Integral Ad Science’s quarterly revenue was up 13.9% on a year-over-year basis. Equities research analysts expect that Integral Ad Science will post 0.26 earnings per share for the current year.

Insiders Place Their Bets

In other news, CEO Lisa Utzschneider sold 12,448 shares of the company’s stock in a transaction dated Tuesday, February 4th. The shares were sold at an average price of $10.61, for a total value of $132,073.28. Following the sale, the chief executive officer now owns 278,650 shares in the company, valued at approximately $2,956,476.50. This represents a 4.28 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders sold a total of 19,109 shares of company stock worth $197,696 in the last 90 days. 2.00% of the stock is owned by company insiders.

Hedge Funds Weigh In On Integral Ad Science

Hedge funds have recently added to or reduced their stakes in the business. Alyeska Investment Group L.P. bought a new position in Integral Ad Science in the 4th quarter worth about $41,543,000. Dimensional Fund Advisors LP grew its stake in shares of Integral Ad Science by 18.1% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,789,996 shares of the company’s stock worth $39,567,000 after purchasing an additional 580,323 shares during the last quarter. Clearline Capital LP bought a new position in shares of Integral Ad Science in the fourth quarter valued at $3,949,000. Invenomic Capital Management LP lifted its holdings in shares of Integral Ad Science by 52.9% during the fourth quarter. Invenomic Capital Management LP now owns 895,061 shares of the company’s stock valued at $9,344,000 after purchasing an additional 309,752 shares during the last quarter. Finally, Ararat Capital Management LP increased its position in shares of Integral Ad Science by 13.4% in the fourth quarter. Ararat Capital Management LP now owns 2,281,912 shares of the company’s stock worth $23,823,000 after acquiring an additional 269,346 shares in the last quarter. Institutional investors and hedge funds own 95.78% of the company’s stock.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.